Wednesday’s Pre-Market Look: Stocks In The News Before The Open
Arrowhead Pharmaceuticals (ARWR) plunged 60% in after-hours trading after it said it will discontinue development of clinical stage drug candidates ARC-520, ARC-521 and ARC-AAT and will reduce its workforce by 30%. Nutanix — Nutanix (NTNX) lost 37 cents per share for its latest quarter, seven cents a share less than expected. The cloud data storage…